Gainers
- Strata Skin Sciences SSKN shares increased by 16.4% to $1.28 during Monday’s after-market session. Strata Skin Sciences’s trading volume hit 643.4K shares by close, accounting for 2649.1% of its average volume over the last 100 days. The company’s market cap stands at $44.4 million.
- Ayala Pharmaceuticals AYLA shares rose 16.09% to $1.01. Ayala Pharmaceuticals’s trading volume hit 152.4K shares by close, accounting for 236.6% of its average volume over the last 100 days. The company’s market cap stands at $14.2 million.
- VistaGen Therapeutics VTGN stock increased by 12.36% to $0.2. This security traded at a volume of 13.4 million shares come close, making up 357.8% of its average volume over the last 100 days. The market value of their outstanding shares is at $41.1 million.
- Cidara Therapeutics CDTX shares moved upwards by 8.39% to $0.71. The company’s market cap stands at $49.0 million.
- Sharecare SHCR shares rose 8.0% to $1.62. The company’s market cap stands at $569.7 million.
- Vor Biopharma VOR shares rose 7.72% to $4.88. The company’s market cap stands at $183.4 million.
Losers
- Heart Test Laboratories HSCS shares fell 15.2% to $1.17 during Monday’s after-market session. The market value of their outstanding shares is at $9.6 million.
- Revelation Biosciences REVB stock declined by 7.93% to $0.93. Revelation Biosciences’s trading volume hit 13.1 million shares by close, accounting for 451.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $14.0 million.
- Dare Bioscience DARE shares declined by 7.28% to $1.02. Today’s trading volume for this security ended up closing at 69.7K shares, which is 6.8 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $86.4 million.
- Legend Biotech LEGN shares fell 6.9% to $47.02. The market value of their outstanding shares is at $7.2 billion.
- Cabaletta Bio CABA stock declined by 6.82% to $1.23. The market value of their outstanding shares is at $35.6 million.
- Dynavax Technologies DVAX shares fell 6.28% to $13.9. The market value of their outstanding shares is at $1.7 billion.
See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga’s automated content engine and reviewed by an editor.